FDA Inspection 1098879 — Qilu SYNVA Pharmaceutical Co. Ltd
The FDA completed an inspection of Qilu SYNVA Pharmaceutical Co. Ltd on Jul 26, 2019 in Dezhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 26, 2019
- Fiscal Year
- 2019
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Dezhou (China)